Arteriosclerosis and Thrombosis, Vol 11, 71-79, Copyright © 1991 by American Heart Association
ARTICLES |
N Sakai, Y Matsuzawa, K Hirano, S Yamashita, S Nozaki, Y Ueyama, M Kubo and S Tarui
Second Department of Internal Medicine, Osaka, University Medical School, Japan.
By equilibrium density gradient ultracentrifugation, we analyzed the chemical composition and particle size of low density lipoproteins (LDLs) in 16 subfractions separated from the LDL fractions (1.019 less than d less than 1.063 g/ml) of two hyperalphalipoproteinemic patients who had a deficiency of cholesteryl ester transfer protein (CETP). The LDLs of these patients comprised a group of heterogeneous lipoprotein particles distributed almost equally in a wide density range from d = 1.025 g/ml to d = 1.053 g/ml, whereas LDLs from normal controls were a homogeneous group of lipoprotein particles distributed in a narrow density range from d = 1.030 g/ml to d = 1.046 g/ml. The LDL in each subfraction derived from the patients' plasma samples was poor in cholesteryl ester and rich in triglycerides and apolipoproteins. Each subfraction of normal control LDL contained only one species of homogeneous LDL particles, which progressively decreased in size with an increase in the density of the fraction. In contrast, each subfraction of patient LDL contained two species of LDL particles: smaller LDLs existed, in addition to those that were found to be identical to the normal control LDL particles observed in the corresponding subfractions. The intermediate density lipoproteins of the two patients were also composed of two species of lipoproteins. From these results, we speculate that two metabolic pathways may exist in the LDL formation process. In this process, the transfer of cholesteryl ester from high density lipoproteins by CETP may convert the smaller lipoprotein particles to the larger ones, forming the homogeneous LDL species.
This article has been cited by other articles:
![]() |
W. A. van der Steeg, G. K. Hovingh, A. H. E. M. Klerkx, B. A. Hutten, I. C. Nootenboom, J. H. M. Levels, A. van Tol, G. M. Dallinga-Thie, A. H. Zwinderman, J. J. P. Kastelein, et al. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians J. Lipid Res., March 1, 2007; 48(3): 674 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, Z. Li, M. R. Hojjati, D. Jang, T. P. Beyer, G. Cao, A. R. Tall, and X.-C. Jiang Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism J. Lipid Res., September 1, 2006; 47(9): 2011 - 2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. de Grooth, A. H. E. M. Klerkx, E. S. G. Stroes, A. F. H. Stalenhoef, J. J. P. Kastelein, and J. A. Kuivenhoven A review of CETP and its relation to atherosclerosis J. Lipid Res., November 1, 2004; 45(11): 1967 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Brewer Jr, A. T. Remaley, E. B. Neufeld, F. Basso, and C. Joyce Regulation of Plasma High-Density Lipoprotein Levels by the ABCA1 Transporter and the Emerging Role of High-Density Lipoprotein in the Treatment of Cardiovascular Disease Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1755 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bosse, L. Perusse, and M.-C. Vohl Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations J. Lipid Res., June 1, 2004; 45(6): 1008 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Brewer Jr. High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 387 - 391. [Full Text] |
||||
![]() |
P. J. Barter, H. B. Brewer Jr, M. J. Chapman, C. H. Hennekens, D. J. Rader, and A. R. Tall Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 160 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Berneis and R. M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagano, S. Yamashita, K.-i. Hirano, M. Ito, T. Maruyama, M. Ishihara, Y. Sagehashi, T. Oka, T. Kujiraoka, H. Hattori, et al. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader (R) assay J. Lipid Res., July 1, 2002; 43(7): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gander, P. Eller, S. Kaser, I. Theurl, D. Walter, T. Sauper, A. Ritsch, J. R. Patsch, and B. Foger Molecular characterization of rabbit phospholipid transfer protein: choroid plexus and ependyma synthesize high levels of phospholipid transfer protein J. Lipid Res., April 1, 2002; 43(4): 636 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kratz, E. Gulbahce, A. von Eckardstein, P. Cullen, A. Cignarella, G. Assmann, and U. Wahrburg Dietary Mono- and Polyunsaturated Fatty Acids Similarly Affect LDL Size in Healthy Men and Women J. Nutr., April 1, 2002; 132(4): 715 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Fusegawa, K. L. Kelley, J. K. Sawyer, R. N. Shah, and L. L. Rudel Influence of dietary fatty acid composition on the relationship between CETP activity and plasma lipoproteins in monkeys J. Lipid Res., November 1, 2001; 42(11): 1849 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagano, S. Yamashita, K.-i. Hirano, T. Kujiraoka, M. Ito, Y. Sagehashi, H. Hattori, N. Nakajima, T. Maruyama, N. Sakai, et al. Point Mutation (-69 G{->}A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 985 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Talmud, K. L. Edwards, C. M. Turner, B. Newman, J. M. Palmen, S. E. Humphries, and M. A. Austin Linkage of the Cholesteryl Ester Transfer Protein (CETP) Gene to LDL Particle Size : Use of a Novel Tetranucleotide Repeat Within the CETP Promoter Circulation, May 30, 2000; 101(21): 2461 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Hirano, S. Yamashita, Y. Nakagawa, T. Ohya, F. Matsuura, K. Tsukamoto, Y. Okamoto, A. Matsuyama, K. Matsumoto, J.-i. Miyagawa, et al. Expression of Human Scavenger Receptor Class B Type I in Cultured Human Monocyte-Derived Macrophages and Atherosclerotic Lesions Circ. Res., July 9, 1999; 85(1): 108 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ritsch, H. Drexel, F. W. Amann, C. Pfeifhofer, and J. R. Patsch Deficiency of Cholesteryl Ester Transfer Protein : Description of the Molecular Defect and the Dissociation of Cholesteryl Ester and Triglyceride Transport in Plasma Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3433 - 3441. [Abstract] [Full Text] |
||||
![]() |
C. J. Packard and J. Shepherd Lipoprotein Heterogeneity and Apolipoprotein B Metabolism Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3542 - 3556. [Abstract] [Full Text] |
||||
![]() |
K.-i. Hirano, S. Yamashita, N. Nakajima, T. Arai, T. Maruyama, Y. Yoshida, M. Ishigami, N. Sakai, K. Kameda-Takemura, and Y. Matsuzawa Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1053 - 1059. [Abstract] [Full Text] |
||||
![]() |
K.-A. Rye, N. J. Hime, and PhilipJ. Barter Evidence That Cholesteryl Ester Transfer Protein-mediated Reductions in Reconstituted High Density Lipoprotein Size Involve Particle Fusion J. Biol. Chem., February 14, 1997; 272(7): 3953 - 3960. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Gardner, S. P. Fortmann, and R. M. Krauss Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women JAMA, September 18, 1996; 276(11): 875 - 881. [Abstract] [PDF] |
||||
![]() |
K.-i. Hirano, S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, et al. Atherosclerotic Disease in Marked Hyperalphalipoproteinemia : Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1849 - 1856. [Abstract] [Full Text] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |